Vilazodone

Major Depressive Disorder

Vilazodone is primarily used to treat major depressive disorder (MDD). This condition involves persistent feelings of sadness, loss of interest in daily activities, and other emotional or physical symptoms that interfere with a person's ability to function.

As an atypical antidepressant, vilazodone works by helping to restore the balance of certain natural chemicals in the brain, specifically serotonin. By modulating these chemical levels, the medication can help improve mood, sleep, and appetite in individuals with depression.

Treatment Overview

• Target Population: This medication is indicated for use in adults.
• Administration: It is typically taken once daily. Taking the medication with food is necessary to ensure the body absorbs it properly.
• Effectiveness: It may take several weeks of regular use before the full antidepressant effects are noticed.

Mechanism of Action

Vilazodone belongs to a class of medications known as selective serotonin reuptake inhibitors (SSRIs) and partial serotonin receptor agonists. While the exact way it works is not fully understood, it is believed to help treat depression by affecting certain natural chemicals in the brain.

Serotonin Regulation

Serotonin is a neurotransmitter that helps maintain mental balance and mood. Vilazodone works in two primary ways:

• Serotonin Reuptake Inhibition: It prevents the brain from reabsorbing serotonin too quickly. This increases the amount of serotonin available to send messages between nerve cells.
• Partial Agonism: It also binds to specific serotonin receptors called 5-HT1A receptors. By acting as a partial agonist at these sites, it further influences how serotonin functions in the central nervous system.

By balancing these chemical signals, vilazodone helps improve the symptoms of major depressive disorder.

Common Side Effects

The most frequently reported side effects of vilazodone include:

• Diarrhea
• Nausea or vomiting
• Dizziness
• Dry mouth
• Trouble sleeping (insomnia)
• Gas or bloating
• Joint pain

Sexual Side Effects

Some people may experience sexual problems while taking vilazodone, such as:

• Decreased sex drive
• Difficulty reaching orgasm or delayed ejaculation
• Erectile dysfunction

Serious Side Effects

Contact a healthcare provider immediately if you experience any of the following serious symptoms:

• Seizures
• Unusual bruising or bleeding
• Signs of low sodium levels, such as headache, confusion, memory problems, weakness, or feeling unsteady
• Vision changes, including eye pain, swelling, or redness in or around the eye
• Manic episodes, which may involve greatly increased energy, racing thoughts, or reckless behavior

Serotonin Syndrome is a rare but life-threatening condition that requires emergency medical care. Symptoms include agitation, hallucinations, fever, sweating, shivering, fast heart rate, muscle stiffness, twitching, or loss of coordination.

Suicidal Thoughts and Behaviors

Antidepressants can increase the risk of suicidal thinking and behavior in children, adolescents, and young adults. Vilazodone is not approved for use in pediatric patients. It is important to monitor for clinical worsening or sudden changes in mood or behavior.

Serotonin Syndrome

The use of vilazodone can lead to serotonin syndrome, a potentially life-threatening condition. This risk is higher when taken with other serotonergic drugs. Symptoms can include mental status changes, fast heartbeat, muscle twitching, and shivering.

Drug Interactions

Vilazodone should not be used with monoamine oxidase inhibitors (MAOIs) or within 14 days of stopping an MAOI. Combining these drugs can lead to severe reactions.

Bleeding Risk

This medication may increase the risk of bleeding. Caution is needed when using vilazodone alongside aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), or anticoagulants.

Additional Warnings

• Mania and Bipolar Disorder: Vilazodone may activate mania or hypomania. Patients should be screened for bipolar disorder before starting treatment.
• Seizures: This medication should be used with caution in patients with a history of seizures.
• Hyponatremia: Low sodium levels in the blood may occur, especially in elderly patients or those taking certain other medications.
• Discontinuation Syndrome: Stopping vilazodone abruptly can cause withdrawal symptoms. A gradual reduction in dose is usually recommended.
• Angle-Closure Glaucoma: Vilazodone may cause pupillary dilation, which can trigger an angle-closure attack in susceptible individuals.

Pregnancy

There is limited data regarding the use of vilazodone in pregnant women. While animal studies have shown some evidence of developmental toxicity at high doses, there are no adequate and well-controlled studies in humans. Healthcare providers generally consider the risks of untreated depression alongside the potential risks of the medication.

Newborns exposed to antidepressants with serotonin-related activity late in the third trimester may develop complications that require prolonged hospitalization or respiratory support. These complications can include:

• Persistent pulmonary hypertension of the newborn (PPHN).
• Symptoms of neonatal withdrawal or toxicity, such as respiratory distress, seizures, temperature instability, feeding difficulties, and tremors.

Breastfeeding

It is not known whether vilazodone is excreted in human milk. Animal studies have demonstrated that the drug is present in the milk of lactating rats. Because many drugs are present in human milk, caution is advised. Patients should discuss the potential risks and benefits of breastfeeding while taking vilazodone with their healthcare provider.

Available Forms

Vilazodone is available in the following form:

• Oral Tablet: This medication is taken by mouth. It is recommended to take this medication with food to ensure it is absorbed correctly by the body.

Vilazodone is available as a generic drug and under the brand name Viibryd.

FDA Approval and Indications

Vilazodone was approved by the U.S. Food and Drug Administration (FDA) in 2011. It is specifically indicated for the treatment of major depressive disorder (MDD) in adults. The safety and effectiveness of this medication have not been established for pediatric patients.

Boxed Warning

The FDA requires a boxed warning for vilazodone, which is the most serious type of warning for prescription medications. This warning highlights an increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults (up to age 24) during the early stages of antidepressant treatment. Healthcare providers and caregivers are advised to monitor patients closely for any worsening of depression or unusual changes in behavior.

Regulatory Status and Availability

Vilazodone is available as a prescription medication in both brand-name and generic versions. It is not classified as a controlled substance. The FDA continues to monitor the safety profile of vilazodone through post-marketing reports, which include warnings about potential risks such as serotonin syndrome and increased bleeding risks when combined with certain other medications.

Discontinuation Symptoms

If you stop taking vilazodone suddenly, you may experience withdrawal symptoms, often referred to as discontinuation syndrome. These symptoms can be uncomfortable and may include:

• Mood and mental changes: Irritability, anxiety, agitation, confusion, and feelings of uneasiness.
• Physical sensations: Dizziness, headache, nausea, vomiting, sweating, shaking, and numbness or tingling in the hands or feet. Some people also report electric shock-like sensations.
• Sleep disturbances: Difficulty falling or staying asleep, tiredness, and vivid dreams or nightmares.

How to Stop Safely

To prevent or minimize withdrawal symptoms, your doctor will likely recommend a gradual reduction in your dose rather than stopping the medication all at once. If you experience any new or worsening symptoms while tapering off the medication, contact your healthcare provider immediately.